Penserra Capital Management LLC - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 124 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2021$9,000
+50.0%
2,265
+3.2%
0.00%
Q2 2021$6,0000.0%2,195
+13.1%
0.00%
Q1 2021$6,0000.0%1,940
-0.5%
0.00%
Q4 2020$6,0001,9500.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Whitefort Capital Management, LP 11,895,477$24,147,81812.66%
Two Seas Capital LP 8,280,818$16,810,0613.38%
FourWorld Capital Management LLC 1,341,907$2,724,0710.51%
Tejara Capital Ltd 180,077$365,5560.21%
Woodline Partners LP 4,719,903$9,581,4030.11%
Hudson Bay Capital Management LP 8,299,808$16,848,6100.07%
Kepos Capital LP 155,691$3160.06%
Virtus ETF Advisers LLC 40,040$81,2810.05%
Centiva Capital, LP 1,071,705$2,175,5610.05%
Kades & Cheifetz LLC 20,000$40,6000.03%
View complete list of ARBUTUS BIOPHARMA CORP shareholders